Sandoz Biosimilars Strategy: Capturing Market O...

By HEOR Staff Writer

January 23, 2026

Sandoz's Strategic Momentum in Biosimilars and Generics Sandoz's biosimilars strategy, as highlighted during the company's presentation at the 44th Annual J.P. Morgan Healthcare...
Alzheimer’s Care Innovation: Advancing Implementation Across Europe
Navigating Economic Resilience Through Life Sciences Investment
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
Guiding Principles for Ethical AI Integration in Drug Development
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
Johnson & Johnson’s EMA Application for Teclistamab Daratumumab Th...
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Preparing for the EU Health Technology Assessment: Key Insights from the Upco...